Helios Investment Partners’ Interswitch Limited said it has acquired eClat Healthcare Limited. The company did not state the financial implications of the deal.
eClat is a Nigeria-based health technology company with footprints across in Africa.
Interswitch said in an emailed statement that the deal was completed on September 30, 2019. Under the acquisition agreement, the company will be acquiring a 60% stake in eClat through the purchase of shares from current shareholders and subscription to new shares issued by the company.
eClat was founded in 2012 with the aim of assisting healthcare service providers in planning, designing and operating their unique practices with its healthcare technology platform. The company core e-Clinic software including electronic billing, immunization, ante-natal and care pathway functions.
Commenting on the transaction, Mitchell Elegbe, Founder and Group Managing Director/Chief Executive Officer of Interswitch, said: “We are a technology company that is innovating to deliver value across sectors that are critical to Africa’s social and economic development, our acquisition of eClat demonstrates strong progress along this strategy and alignment with our corporate vision.”
